Literature DB >> 20736014

Estradiol lowers intracranial self-stimulation thresholds and enhances cocaine facilitation of intracranial self-stimulation in rats.

Timofey Galankin1, Elena Shekunova, Edwin Zvartau.   

Abstract

Women initiate cocaine use at a younger age and have more complications (e.g., higher rates of major or minor depression) related to cocaine use than men. It has been proposed that estrogens play an important role in these sex differences. The addictive potential of psychoactive drugs can be measured in rats via a rewarding intracranial self-stimulation (ICSS) procedure. The rate-independent method of ICSS allows researchers to assess the "pure" rewarding effect of cocaine without influence of nonspecific motor reactions. The present study aimed to estimate effects of estradiol and a combination of estradiol and cocaine on ICSS in ovariectomized female rats. 17-β-estradiol (5μg/animal/day, 2 days) produced a long-lasting gradual lowering of the thresholds for ICSS. The ability of estradiol to decrease thresholds for ICSS has never been shown previously. Combination of 17-β-estradiol and cocaine (5.0mg/kg, 5 days) produced a greater effect on ICSS thresholds than the effect of either compound alone. No tolerance or sensitization to cocaine developed during the study. Present findings suggest estradiol increases sensitivity of the brain reward system in rats, which may have an important implication in understanding sex differences in cocaine effects.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736014     DOI: 10.1016/j.yhbeh.2010.08.006

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  10 in total

1.  How reward and emotional stimuli induce different reactions across the menstrual cycle.

Authors:  Michiko Sakaki; Mara Mather
Journal:  Soc Personal Psychol Compass       Date:  2012-01-01

2.  Cocaine-induced reward enhancement measured with intracranial self-stimulation in rats bred for low versus high saccharin intake.

Authors:  Anna K Radke; Natalie E Zlebnik; Nathan A Holtz; Marilyn E Carroll
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

Review 3.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

4.  Alk is a transcriptional target of LMO4 and ERα that promotes cocaine sensitization and reward.

Authors:  Amy W Lasek; Julie Gesch; Francesco Giorgetti; Viktor Kharazia; Ulrike Heberlein
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

5.  Jugular Vein Catheter Design and Cocaine Self-Administration Using Mice: A Comprehensive Method.

Authors:  Gia Valles; Jessica L Huebschman; Elsbeth Chow; Corinne Kelly; Yuhong Guo; Laura N Smith
Journal:  Front Behav Neurosci       Date:  2022-06-15       Impact factor: 3.617

6.  Sex-Specific Regulation of Depression, Anxiety-Like Behaviors and Alcohol Drinking in Mice Lacking ENT1.

Authors:  Christina L Ruby; Denise L Walker; Joyce An; Jason Kim; Doo-Sup Choi
Journal:  J Addict Res Ther       Date:  2011-12-25

7.  Sex differences in cocaine conditioned place preference in C57BL/6J mice.

Authors:  Elisa R Hilderbrand; Amy W Lasek
Journal:  Neuroreport       Date:  2014-01-22       Impact factor: 1.837

8.  Studying Sex Differences in Rodent Models of Addictive Behavior.

Authors:  Anna K Radke; Elizabeth A Sneddon; Sean C Monroe
Journal:  Curr Protoc       Date:  2021-04

9.  Estrogen Receptor β in the Nucleus Accumbens Regulates the Rewarding Properties of Cocaine in Female Mice.

Authors:  Rosalba Satta; Briana Certa; Donghong He; Amy W Lasek
Journal:  Int J Neuropsychopharmacol       Date:  2018-04-01       Impact factor: 5.176

10.  Estradiol increases the sensitivity of ventral tegmental area dopamine neurons to dopamine and ethanol.

Authors:  Bertha J Vandegrift; Chang You; Rosalba Satta; Mark S Brodie; Amy W Lasek
Journal:  PLoS One       Date:  2017-11-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.